WHO lauds SL for fully vaccinating 50% of population
2 years ago
Share on
The World Health Organisation (WHO) has lauded Sri Lanka for fully vaccinating over 50% of its total population, calling it an important milestone and far above WHO’s target for all countries.
“Sri Lanka reached an important milestone today with 50% of the population fully vaccinated. Vaccinate, vaccinate, vaccinate has been the chant for the pandemic response. This is based on the science of vaccines and global evidence that Covid-19 vaccines can protect against severe disease as well as limit the transmission of the virus,” it said in a press release Saturday (18).
WHO has called for all countries to vaccinate 10% of their population by the end of September and 40% by the end of the year. In the context of supply constraints, the Strategic Advisory Group of Experts on Immunisation (SAGE) recommended prioritising vaccinations for healthcare and frontline workers, the elderly (60 and over), and those with co-morbidities. For this, WHO has led on the COVAX facility for equitable access to Covid-19 vaccines. Through its Advance Market Commitment (AMC) mechanism, COVAX supports 92 low and middle-income economies, including Sri Lanka, to access donor-funded vaccines specifically for SAGE recommended priority groups. COVAX also has a cost-sharing mechanism for countries to access additional doses.
The WHO projected that Sri Lanka would soon surpass its own targets.
“President Rajapaksa’s ambitious vaccination effort that spearheads Sri Lanka’s Covid-19 response has long surpassed WHO’s targets. It is also likely to surpass its own target of vaccinating 60% of the population by 31 December. At the centre of this success is Sri Lanka’s strong primary healthcare foundation. This has been adapted quickly for Covid-19 vaccine readiness in a whole of government and whole of society approach. Vaccine deployment was initiated with coverage of frontline workers and then expanded progressively to all over 60 and, now, over 30 years of age. Further, given vaccine supplies, the expansion of coverage was managed strategically starting with the high-risk geographical area of the Western province and subsequent rollout to other regions. In the context of the predominance of the Delta variant, nationwide coverage with increasing eligibility will reduce transmissions and severe infections,” added WHO.
Sri Lanka has used six vaccines – AstraZeneca (Japan), Covishield, Moderna, Pfizer, Sinopharm, and Sputnik V. All except the Sputnik V vaccine has WHO Emergency Use License (EUL). So far, Sri Lanka has received 27 million vaccine doses, of which 12.2% were accessed through COVAX AMC.